Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
7.6 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Health insurance; cost-sharing payments for prescription insulin drugs. | Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $30 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill incorporates HB 1403. | us/states/va | Virginia General Assembly | 2020 | HB 66 | Virginia HB 66 (2020) |
|
enacted |
|
4 | 34 | 7 | 2019-12-05 | 2020-04-08 | openstates | ocd-bill/613b6582-3319-48ec-bb57-6a7ef6635829 | https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+HB66 | a2edcc375b650b838725c1c6acf1741a213a1cbe49fd383dd77e916e088848c8 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 66 (2020) — Health insurance; cost-sharing payments for prescription insulin drugs.
Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $30 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill incorporates HB 1403.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Acts of Assembly Chapter text (CHAP0881) (committee substitute) — source
- Bill text as passed House and Senate (HB66ER) (committee substitute) — source
- Engrossed by House - committee substitute HB66H1 (committee substitute) — source
- Impact statement from SCC (HB66) (committee substitute) — source
Votes
- Reported from Commerce and Labor with amendment (9-Y 6-N) — 9–6 (pass) · upper
- VOTE: Passage (98-Y 1-N) — 97–1 (pass) · lower
- Subcommittee recommends reporting (4-Y 2-N) — 4–2 (pass) · lower
- Passed Senate with amendment (24-Y 16-N) — 24–16 (pass) · upper
- Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Labor and Commerce with substitute (17-Y 1-N) — 17–1 (pass) · lower
- VOTE: Adoption (88-Y 4-N) — 87–4 (pass) · lower
Sponsors
- Lee J. Carter — primary (person)
- Alex Q. Askew — cosponsor (person)
- Alfonso H. Lopez — cosponsor (person)
- Charniele L. Herring — cosponsor (person)
- Chris L. Hurst — cosponsor (person)
- Clinton L. Jenkins — cosponsor (person)
- Dan I. Helmer — cosponsor (person)
- Danica A. Roem — cosponsor (person)
- Dawn M. Adams — cosponsor (person)
- Delores L. McQuinn — cosponsor (person)
- Don L. Scott — cosponsor (person)
- Glenn R. Davis — cosponsor (person)
- Hala S. Ayala — cosponsor (person)
- Ibraheem S. Samirah — cosponsor (person)
- James A. "Jay" Leftwich — cosponsor (person)
- Jeffrey M. Bourne — cosponsor (person)
- Jeion A. Ward — cosponsor (person)
- Jerrauld C. "Jay" Jones — cosponsor (person)
- Joseph D. Morrissey — cosponsor (person)
- Joshua G. Cole — cosponsor (person)
- Kathleen Murphy — cosponsor (person)
- Kathy K.L. Tran — cosponsor (person)
- Kenneth R. Plum — cosponsor (person)
- Lashrecse D. Aird — cosponsor (person)
- Marcia S. "Cia" Price — cosponsor (person)
- Marcus B. Simon — cosponsor (person)
- Mark H. Levine — cosponsor (person)
- Mark L. Keam — cosponsor (person)
- Martha M. Mugler — cosponsor (person)
- Nancy D. Guy — cosponsor (person)
- Patrick A. Hope — cosponsor (person)
- Paul E. Krizek — cosponsor (person)
- Rodney T. Willett — cosponsor (person)
- Roslyn C. Tyler — cosponsor (person)
- Sally L. Hudson — cosponsor (person)
- Sam Rasoul — cosponsor (person)
- Shelly A. Simonds — cosponsor (person)
- Steve E. Heretick — cosponsor (person)
- Suhas Subramanyam — cosponsor (person)
- Vivian E. Watts — cosponsor (person)
- Wendy W. Gooditis — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2019-12-05 Prefiled and ordered printed; offered 01/08/20 20100840D
introduction - 2019-12-05 Referred to Committee on Labor and Commerce
referral-committee - 2020-01-14 Assigned L & C sub: Subcommittee #2
referral-committee - 2020-01-16 Impact statement from SCC (HB66)
- 2020-01-16 Subcommittee recommends reporting (4-Y 2-N)
- 2020-01-28 Committee substitute printed 20107156D-H1
substitution - 2020-01-28 Incorporates HB1403 (Leftwich)
- 2020-01-28 Reported from Labor and Commerce with substitute (17-Y 1-N)
committee-passage - 2020-01-30 Read first time
reading-1 - 2020-01-31 Read second time
reading-2 - 2020-01-31 Passed by temporarily
- 2020-01-31 Committee substitute agreed to 20107156D-H1
- 2020-01-31 Engrossed by House - committee substitute HB66H1
- 2020-02-03 Read third time and passed House (98-Y 1-N)
passage, reading-3 - 2020-02-03 VOTE: Passage (98-Y 1-N)
- 2020-02-04 Constitutional reading dispensed
- 2020-02-04 Referred to Committee on Commerce and Labor
referral-committee - 2020-02-04 Impact statement from SCC (HB66H1)
- 2020-03-02 Reported from Commerce and Labor with amendment (9-Y 6-N)
committee-passage - 2020-03-04 Constitutional reading dispensed (40-Y 0-N)
- 2020-03-05 Read third time
reading-3 - 2020-03-05 Reading of amendment waived
- 2020-03-05 Committee amendment agreed to
- 2020-03-05 Engrossed by Senate as amended
- 2020-03-05 Passed Senate with amendment (24-Y 16-N)
passage - 2020-03-05 Senate amendment agreed to by House (88-Y 4-N)
- 2020-03-05 VOTE: Adoption (88-Y 4-N)
- 2020-03-12 Enrolled
- 2020-03-12 Signed by Speaker
- 2020-03-12 Signed by President
- 2020-03-13 Impact statement from SCC (HB66ER)
- 2020-03-17 Enrolled Bill communicated to Governor on March 17, 2020
- 2020-03-17 Governor's Action Deadline 11:59 p.m., April 11, 2020
- 2020-04-08 Approved by Governor-Chapter 881 (effective 7/1/20)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/613b6582-3319-48ec-bb57-6a7ef6635829. Confidence: reported (aggregated from official Virginia legislature records).